In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The idea of buying American and hiring American is good news for defense, ag and energy stocks, says Jim Cramer.
This biopharma company's Relistor drug should send revenues sharply higher this year.
This biopharma company's Relistor drug should send revenues sharply higher next year.
Any boost in infrastructure spending is likely to hit in 2018 or even 2019, rather than next year.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.